 |
|
MRU conducts Phase II, III, and IV clinical trials in the following therapeutic areas:
- Cardiology
- Critical Care
- Endocrinology
- Gastroenterology
- Geriatrics
- Hepatology
- Hematology/Oncology
- Internal Medicine/Primary Care
- Sleep Disorders
- Dermatology
|
- Infectious Disease
- Neurology
- Podiatry
- Psychiatry
- Pulmonology
- Rheumatology
- Urology
- Womens Health
- Nutriceuticals
- Pediatrics
|
We have successfully conducted studies for the following companies:
| Pharmaceutical Companies |
|
AGI Therapeutics
Alizyme Therapeutics Limited
Altana
Amylin Pharmaceuticals
AstraZeneca
Aventis
Biodel
Biovail Technologies
Boehringer Ingelheim Pharmaceuticals, Inc.
Bristol-Myers Squibb
Celltech R & D
Eisai Medical Research
Eli Lilly
Forest Laboratories, Inc.
Genentech, Inc.
GlaxoSmithKline
Inflabloc Pharmaceuticals
|
Janssen Pharmaceutical, Inc.
Merck & Co., Inc.Novartis
Novo Nordisk
Ortho-McNeil
Otsuka Maryland Research Institute, Inc.
Pfizer
Pliva Research Institute, Ltd.
Pozen
Salix Pharmaceuticals
SEPRACOR
SkyePharma
Sucampo Pharmaceuticals
Takeda Pharmaceuticals North America, Inc.
Targacept, Inc
Wyeth
Yamanouchi Pharma America, Inc. |
| CROs |
|
Advanced Biologics
B & B Clinical Innovations, Inc.
Beardsworth
Clinical Trial Management Service, Inc.
Clinmetrics Research Associates
Covance
Global IQ
ICON
Integrium, LLC
Kendle International Inc.
Lineberry Research Associates |
MDS Pharma
Medpace
Omnicare
Parexel
PharmaNet
PPD Development
PRA International
Quintiles
Research Pharmaceutical Services
Target Research Associates
UBC |
|
